X4 Pharmaceuticals Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

3.75

0.00 (0.00%)

At close: May 02, 2025, 2:26 PM

X4 Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-37.45M	-101.17M	-93.87M	-88.7M	-62.13M	-52.81M	-43.02M	-33.88M	-22.98M
Depreciation & Amortization	796K	419K	513K	499K	351K	103K	155K	195K	285K
Stock-Based Compensation	8.2M	8.69M	5.2M	6.18M	5.43M	2.05M	5.62M	906K	644K
Other Working Capital	n/a	-890K	2.31M	-2.66M	-5.09M	-484K	-3.12M	3.24M	-1.78M
Other Non-Cash Items	-102.45M	-4.79M	5.32M	19.29M	7.38M	7.99M	804K	1.75M	2.32M
Deferred Income Tax	n/a	n/a	n/a	-6.68M	-5.78M	-2.15M	n/a	-269K	-1.39M
Change in Working Capital	n/a	344K	5.74M	-1.5M	-4.06M	-3.24M	-4.46M	3.42M	-517K
Operating Cash Flow	-130.9M	-96.51M	-77.1M	-70.91M	-58.82M	-48.05M	-40.9M	-27.87M	-21.64M
Capital Expenditures	-326K	-60K	-103K	-615K	-1.36M	-174K	-34K	-42K	-73K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	26.41M	n/a	n/a	n/a
Purchase of Investments	-57.13M	-16.82M	-4.8M	n/a	n/a	n/a	n/a	n/a	-65K
Sales Maturities Of Investments	26.45M	2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	98M	n/a	4.8M	n/a	n/a	1M	n/a	76K	-65K
Investing Cash Flow	66.99M	-14.88M	-103K	-615K	-1.36M	27.23M	-34K	34K	-138K
Debt Repayment	20M	20.44M	-795K	n/a	12.39M	481K	2.4M	3.28M	12.76M
Common Stock Repurchased	n/a	n/a	n/a	-2M	n/a	n/a	-1.13M	-197K	-87K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	294K	8.08M	-4.61M	260K	284K	792K	7K	-7.87M	-30K
Financial Cash Flow	20.29M	88.52M	117.23M	74.25M	12.39M	140.66M	-4.53M	101.26M	18.15M
Net Cash Flow	-43.77M	-22.78M	39.92M	2.41M	-47.38M	119.59M	-45.75M	73.76M	-3.72M
Free Cash Flow	-131.23M	-96.57M	-77.2M	-71.52M	-60.18M	-48.23M	-40.94M	-27.91M	-21.71M